BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10898677)

  • 1. Dose-dependent pharmacokinetics of amphotericin B lipid complex in rabbits.
    Walsh TJ; Jackson AJ; Lee JW; Amantea M; Sein T; Bacher J; Zech L
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2068-76. PubMed ID: 10898677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphotericin B lipid complex or amphotericin B multiple-dose administration to rabbits with elevated plasma cholesterol levels: pharmacokinetics in plasma and blood, plasma lipoprotein levels, distribution in tissues, and renal toxicities.
    Ramaswamy M; Peteherych KD; Kennedy AL; Wasan KM
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1184-91. PubMed ID: 11257033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations.
    Groll AH; Lyman CA; Petraitis V; Petraitiene R; Armstrong D; Mickiene D; Alfaro RM; Schaufele RL; Sein T; Bacher J; Walsh TJ
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3418-23. PubMed ID: 17005824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, distribution in serum lipoproteins and tissues, and renal toxicities of amphotericin B and amphotericin B lipid complex in a hypercholesterolemic rabbit model: single-dose studies.
    Wasan KM; Kennedy AL; Cassidy SM; Ramaswamy M; Holtorf L; Chou JW; Pritchard PH
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3146-52. PubMed ID: 9835506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavior of amphotericin B lipid complex in plasma in vitro and in the circulation of rats.
    Bhamra R; Sa'ad A; Bolcsak LE; Janoff AS; Swenson CE
    Antimicrob Agents Chemother; 1997 May; 41(5):886-92. PubMed ID: 9145839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative drug disposition, urinary pharmacokinetics, and renal effects of multilamellar liposomal nystatin and amphotericin B deoxycholate in rabbits.
    Groll AH; Mickiene D; Petraitis V; Petraitiene R; Alfaro RM; King C; Piscitelli SC; Walsh TJ
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3917-25. PubMed ID: 14638502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits.
    Lee JW; Amantea MA; Francis PA; Navarro EE; Bacher J; Pizzo PA; Walsh TJ
    Antimicrob Agents Chemother; 1994 Apr; 38(4):713-8. PubMed ID: 8031034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary extraction and accumulation of lipid formulations of amphotericin B.
    Matot I; Pizov R
    Crit Care Med; 2000 Jul; 28(7):2528-32. PubMed ID: 10921589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular distribution of intravenously administered lipid formulations of amphotericin B in a rabbit model.
    Goldblum D; Rohrer K; Frueh BE; Theurillat R; Thormann W; Zimmerli S
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3719-23. PubMed ID: 12435667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of amphotericin B lipid complex in a rabbit model of coccidioidal meningitis.
    Capilla J; Clemons KV; Sobel RA; Stevens DA
    J Antimicrob Chemother; 2007 Sep; 60(3):673-6. PubMed ID: 17646202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphotericin B lipid complex for the treatment of invasive fungal infections.
    Linden PK
    Expert Opin Pharmacother; 2003 Nov; 4(11):2099-110. PubMed ID: 14596663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacoeconomic analysis of amphotericin B lipid complex versus liposomal amphotericin B in the treatment of fungal infections.
    Kuti JL; Kotapati S; Williams P; Capitano B; Nightingale CH; Nicolau DP
    Pharmacoeconomics; 2004; 22(5):301-10. PubMed ID: 15061680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of amphotericin B deoxycholate, liposomal amphotericin B, and amphotericin B lipid complex in an in vitro model of invasive pulmonary aspergillosis.
    Lestner JM; Howard SJ; Goodwin J; Gregson L; Majithiya J; Walsh TJ; Jensen GM; Hope WW
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3432-41. PubMed ID: 20439615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphotericin B lipid complex.
    Rapp RP; Gubbins PO; Evans ME
    Ann Pharmacother; 1997 Oct; 31(10):1174-86. PubMed ID: 9337444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
    Lewis RE; Liao G; Hou J; Chamilos G; Prince RA; Kontoyiannis DP
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1253-8. PubMed ID: 17261624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit model.
    Cannon JP; Fiscella R; Pattharachayakul S; Garey KW; De Alba F; Piscitelli S; Edward DP; Danziger LH
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2112-7. PubMed ID: 12714650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of an abbreviated induction regimen of amphotericin B deoxycholate for cryptococcal meningoencephalitis: 3 days of therapy is equivalent to 14 days.
    Livermore J; Howard SJ; Sharp AD; Goodwin J; Gregson L; Felton T; Schwartz JA; Walker C; Moser B; Müller W; Harrison TS; Perfect JR; Hope WW
    mBio; 2014 Jan; 5(1):e00725-13. PubMed ID: 24473125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacies of lipid-complexed amphotericin B and liposomal amphotericin B against coccidioidal meningitis in rabbits.
    Clemons KV; Capilla J; Sobel RA; Martinez M; Tong AJ; Stevens DA
    Antimicrob Agents Chemother; 2009 May; 53(5):1858-62. PubMed ID: 19273680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of amphotericin B lipid complex in critically ill patients undergoing continuous venovenous haemodiafiltration.
    Malone ME; Corrigan OI; Kavanagh PV; Gowing C; Donnelly M; D'Arcy DM
    Int J Antimicrob Agents; 2013 Oct; 42(4):335-42. PubMed ID: 23920093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic-pharmacodynamic comparison of amphotericin B (AMB) and two lipid-associated AMB preparations, liposomal AMB and AMB lipid complex, in murine candidiasis models.
    Andes D; Safdar N; Marchillo K; Conklin R
    Antimicrob Agents Chemother; 2006 Feb; 50(2):674-84. PubMed ID: 16436726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.